News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

Al's Comment:

 This is so sad. I had high hopes for this trial. The earlier phase 2 trial reported very good results.  The details have not been released yet - would love to see how the 2 trials differed and why the phase 3 trial did not show a benefit when the phase 2 showed such a large benefit. 


Posted on: 03/08/2018

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740